The ability of both bulk TF/EGCG and TF/EGCG-loaded PLGA-NPs to inhibit proliferation of lung carcinoma, cervical carcinoma and acute monocytic leukemia cells was determined. This evidence concerns the gene TF and lung carcinoma.